Copyright: ©Author(s) 2026.
World J Cardiol. Mar 26, 2026; 18(3): 116789
Published online Mar 26, 2026. doi: 10.4330/wjc.v18.i3.116789
Published online Mar 26, 2026. doi: 10.4330/wjc.v18.i3.116789
Figure 3 Forest plot for corrected Thrombolysis in Myocardial Infarction frame count.
The pooled and subgroup analysis showed no significant difference between nicoranadil and the control group. Substantial heterogeneity was noted in the overall and subgroup analyses. CI: Confidence interval; IV: Intravenous; IC: Intracoronary.
- Citation: Ahmed S, Ahmad E, Ashraf H, Ain HU, Ahmad S, Akram U, Basit J, Hassan IN, Ullah I, Ahmed R, Fonarow GC, Cortese B. Nicorandil in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis. World J Cardiol 2026; 18(3): 116789
- URL: https://www.wjgnet.com/1949-8462/full/v18/i3/116789.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i3.116789